Results 171 to 180 of about 108,718 (219)

Plasmodium vivax and Plasmodium falciparum mixed infections in human and mosquito hosts: The impact of multi-species infection on parasite densities and transmission to mosquitoes. [PDF]

PLoS Negl Trop Dis
Chali W, Ejigu LA, Atele T, Sisay S, Jebessa G, Habtamu G, Abdo M, Shimelash A, Demisse M, Bezabih MK, Nibret D, Gizat A, Beyene KG, Abi K, Zeleke AJ, Getnet B, Amare ZS, Beyena T, Endale T, Dechasa M, Massebo F, Kassa FA, Challi S, Mamo H, Drakeley C, Bousema T, Tadesse FG.   +26 more
europepmc   +1 more source

Enhanced YOLO-based framework and benchmarking for automated Plasmodium vivax detection. [PDF]

Parasitol Res
Prathap VM, Yadav S.
europepmc   +1 more source

Partial characterization of a cysteine protease inhibitor of Plasmodium vivax. [PDF]

Parasites Hosts Dis
Võ TC, Kang JM, Lê HG, Na BK.
europepmc   +1 more source

Therapeutic efficacy, safety and gametocyte clearance after antimalarial treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Northeast Ethiopia. [PDF]

Sci Rep
Debash H, Tilahun M, Desale S, Getnet E, Mohammed AE.   +4 more
europepmc   +1 more source

Associations between weather and Plasmodium vivax malaria in an Amazonian elimination setting: a distributed lag analysis from 2017 to 2024. [PDF]

Malar J
Barratt Heitmann G, Wu X, Nguyen AT, Altamirano-Quiroz A, Fine SR, Fernandez-Camacho B, Barja A, Cava R, Soto-Calle V, Rodriguez H, Carrasco-Escobar G, Bennett A, Llanos-Cuentas A, Mordecai EA, Hsiang MS, Benjamin-Chung J.   +15 more
europepmc   +1 more source

Risk perceptions of high-dose primaquine and tafenoquine among <i>Plasmodium vivax</i> malaria stakeholders in Ethiopia: a qualitative study. [PDF]

BMJ Glob Health
Mwaura M, Engel N, Kejela M, Korra KG, Wodaj T, Shibiru Degaga T, Ley B, Price R, Krumeich A, Thriemer K.   +9 more
europepmc   +1 more source

Dissemination of EFFORT trial results in Indonesia: a stakeholder meeting report on tafenoquine and primaquine for radical cure of Plasmodium vivax. [PDF]

Malar J
Pasaribu AP, Jimanto V, Ainur F, Saragih NR, Hadi H, Siagian DSP, Sinaga BJ, Satyagraha AW, Laihad FJ, Diptyanusa A, Ubra RR, Tekege O, Darmayanti L, Herdiana H, Adella J, Mannion K, Curry E, Poespoprodjo JR, Kenangalem E, Burdam FH, Sutanto I, Nelwan EJ, Ganadhi GJ, Shrestha B, Mnjala H, Hawley WA, Prameswari HD, Theodora M, Silalahi FSM, Susanto H, Immanuella F, Puspadewi RT, Fajariyani SB, Samad I, Supriyanto D, Muhafilah N, Isa R, Price RN, Thriemer K.   +38 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Plasmodium vivax in India

Trends in Parasitology, 2008
Four Plasmodium species cause malaria in humans: Plasmodium vivax is the most widespread and results in pronounced morbidity. India (population >1 billion) is a major contributor to the burden of vivax malaria. With a resurgence in interest concerning the neglected burden of vivax malaria and the completion of the P.
Hema, Joshi, Surendra K, Prajapati, Anju, Verma, Simon, Kang'a, Jane M, Carlton   +4 more
openaire   +2 more sources

Cultivation of Plasmodium vivax

Trends in Parasitology, 2008
Establishment of a continuous line of Plasmodium vivax parasite is crucial to understand the parasite's biology; however, this has not yet been achieved. Beginning in the 19th century, there were several efforts to cultivate this malaria parasite but without much success until the late 1980s.
Rachanee, Udomsangpetch, Osamu, Kaneko, Kesinee, Chotivanich, Jetsumon, Sattabongkot   +3 more
openaire   +2 more sources

Focus on Plasmodium vivax

Trends in Parasitology, 2002
In Bangkok, Thailand, 3-8 February 2002, the Multilateral Initiative on Malaria convened the first malaria conference, Vivax Malaria Research: 2002 and Beyond, devoted entirely to Plasmodium vivax research.
openaire   +2 more sources